Market Forecast by Countries (United States, Canada), By Solution (University of Wisconsin (UW), Custodial HTK, Perfadex, Others), By Organ Type (Kidneys, Liver, Lung, Heart, Others), By Preservation Technology (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion, Others) And Competitive Landscape
Product Code: ETC075192 | Publication Date: Aug 2021 | Updated Date: Mar 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 200 | No. of Figures: 90 | No. of Tables: 30 | |
Report Name | North America Organ Preservation Market |
Forecast Period | 2025-2031 |
Market Size |
USD 442 million by 2031 |
CAGR | 6.4% |
Growing Sector | Healthcare and Biotechnology |
North America Organ Preservation Market report thoroughly covers the market by solution, by organ type, by preservation technology and key countries. The market report provides an unbiased and detailed analysis of the ongoing market trends, opportunities/high growth areas, and market drivers which would help the stakeholders to devise and align their market strategies according to the current and future market dynamics.
North America Organ Preservation Market Size is projected to reach USD 442 million by 2031, growing at a CAGR of 6.4% during the forecast period from 2025 to 2031. As the number of organ transplantations rises in the United States and Canada, the market is expanding significantly. Key drivers of this growth include the growing need for efficient and long-term organ storage, coupled with innovations that enhance organ viability during transportation and storage.
North America Organ Preservation Industry is experiencing notable growth as the demand for organ transplants continues to rise in the United States and Canada. Advances in preservation technologies and the increasing need for efficient and long-term organ storage are key drivers of this growth. The market's value is set to increase significantly, driven by innovations in preservation techniques, the growing number of organ transplants, and an aging population requiring such medical interventions. With a focus on improving patient outcomes and expanding the donor pool, the North America Organ Preservation Market is expected to witness substantial growth in the coming years. The market is segmented by solution, organ type, and preservation technology, with each category playing a crucial role in this market's expansion.
According to 6Wresearch, the North America Organ Preservation Market is estimated to grow at a CAGR of 6.4% during the forecast period 2025-2031. The surge in demand for organ preservation solutions is fueled by several factors, including a rising prevalence of chronic illnesses such as diabetes, cardiovascular diseases, and hypertension, which are leading causes of organ failure. Furthermore, advancements in medical technology, particularly in organ preservation techniques like normothermic machine perfusion and hypothermic machine perfusion, are playing a crucial role in enhancing the viability and functionality of organs for transplantation. The region benefits from a well-developed healthcare infrastructure and high levels of awareness about organ donation, particularly in the United States, which accounts for the largest North America Organ Preservation Market Share. The increasing success rates of organ transplantation procedures have further boosted demand for effective preservation solutions, creating lucrative opportunities for market players.
Despite its significant growth potential, the North America Organ Preservation Industry faces critical challenges that could hinder its expansion. The most pressing issue is the acute shortage of donor organs, which has become a bottleneck in the transplantation ecosystem. This imbalance between supply and demand places immense pressure on healthcare systems and underscores the importance of maximizing organ preservation techniques to prolong viability. High costs associated with advanced technologies such as hypothermic machine perfusion systems and their maintenance also act as a barrier for smaller medical facilities and underfunded healthcare providers, particularly in remote regions of Canada. Regulatory hurdles, including stringent guidelines for organ donation and transplantation, further complicate the operational landscape. Additionally, the risk of organ damage during storage and transportation poses a significant challenge, emphasizing the need for skilled professionals and robust logistical support.
North America Organ Preservation Market is evolving rapidly, with several key trends shaping its future. One of the most notable trends is the growing adoption of normothermic machine perfusion, which allows organs to remain functional and metabolically active outside the body for extended periods. This innovation reduces the risk of organ damage and significantly improves transplantation outcomes. Another emerging trend is the increasing use of advanced preservation solutions like Custodial HTK and Perfadex, which offer superior compatibility with various organ types and enhance long-term viability. The integration of digital technologies, including IoT-enabled monitoring systems, is also transforming the organ preservation process by enabling real-time tracking and environmental control during transportation. Collaborations between biotech companies, research institutions, and healthcare providers are fostering innovation, while public-private partnerships are driving accessibility to state-of-the-art preservation solutions across the region.
North America Organ Preservation Industry presents a wealth of investment opportunities across multiple segments. With the rising adoption of hypothermic and normothermic machine perfusion technologies, companies specializing in these areas are attracting significant funding from both public and private investors. The growing emphasis on R&D for next-generation preservation solutions is also creating avenues for investment in biotech startups and established firms. Additionally, there is an increasing need for infrastructure development, particularly in remote and underserved areas, which represents a lucrative market for investors focusing on healthcare logistics and transportation. Governments and nonprofit organizations are also providing grants and financial incentives to encourage innovation in organ preservation, further enhancing the appeal for investments in this sector.
The competitive landscape of the North America Organ Preservation Industry is characterized by the presence of several key players driving innovation and market expansion. Companies such as Xvivo Perfusion AB, TransMedics, Inc., and OrganOx Limited lead the market with their advanced technologies in organ preservation, including hypothermic machine perfusion systems and normothermic perfusion devices. Bridge to Life Ltd. and Waters Medical Systems are prominent players offering high-quality solutions for static cold storage and advanced preservation fluids like Custodial HTK and Perfadex. These companies are heavily investing in R&D to develop cost-effective and efficient solutions, ensuring their competitive edge in the market.
Government support plays a pivotal role in driving the North America Organ Preservation Market. In the United States, programs like the National Organ Transplant Act and initiatives by the Department of Health and Human Services have significantly increased public awareness about organ donation and transplantation. These initiatives include education campaigns, financial incentives for organ donors, and investments in research for advanced preservation technologies. In Canada, the government has implemented national organ donation registries and collaborated with healthcare institutions to streamline the transplantation process. Funding for R&D projects focusing on improving organ viability and reducing transportation risks has further strengthened the market's foundation.
North America Organ Preservation Market is expected to witness groundbreaking advancements that could redefine its landscape. The integration of artificial intelligence and machine learning into preservation technologies is anticipated to revolutionize organ viability assessment and real-time monitoring. Innovations in bioengineering and tissue regeneration could address the chronic shortage of donor organs by enabling the artificial creation and preservation of organs. Government initiatives aimed at promoting organ donation awareness and improving transplantation infrastructure are likely to further bolster market growth. Additionally, advancements in cryopreservation techniques and the development of portable, energy-efficient preservation systems are expected to address logistical challenges, making organ preservation more accessible and cost-effective. The emphasis on sustainability and green technologies could also lead to the development of eco-friendly preservation solutions, aligning with global trends in healthcare innovation.
The report offers a comprehensive study of the subsequent market segments and their leading categories.
According to Nikhil, Senior Research Analyst, 6Wresearch, the University of Wisconsin (UW) solution is the most dominant. This preservation solution is widely used, particularly for kidney preservation, and is considered the gold standard for static cold storage. The success of UW is attributed to its ability to provide optimal preservation conditions, ensuring that the organs remain viable for transplantation. The solution is specifically designed to reduce organ damage during cold storage and extends the preservation time.
While more advanced preservation technologies like hypothermic machine perfusion and normothermic machine perfusion are growing in popularity, static cold storage remains the dominating preservation technology in the North America organ preservation market. Static cold storage has long been the go-to method for preserving organs, and its simplicity, cost-effectiveness, and effectiveness in preserving organs for short periods make it a staple in organ preservation.
United States dominates the North America organ preservation market due to its extensive healthcare infrastructure and high demand for organ transplants. With a large patient population in need of organ transplants and a well-established system for organ donation and transplantation, the U.S. remains the leading country in the region. The market's growth in the United States is driven by several factors, including the advanced medical facilities available for organ transplantations, government-backed programs, and widespread adoption of cutting-edge preservation technologies.
The market report covers the following segments:
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Organ Preservation Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Organ Preservation Market Revenues & Volume, 2021 & 2031F |
3.3 North America Organ Preservation Market - Industry Life Cycle |
3.4 North America Organ Preservation Market - Porter's Five Forces |
3.5 North America Organ Preservation Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Organ Preservation Market Revenues & Volume Share, By Solution, 2021 & 2031F |
3.7 North America Organ Preservation Market Revenues & Volume Share, By Organ Type, 2021 & 2031F |
3.8 North America Organ Preservation Market Revenues & Volume Share, By Preservation Technology, 2021 & 2031F |
4 North America Organ Preservation Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Organ Preservation Market Trends |
6 North America Organ Preservation Market, 2021 - 2031 |
6.1 North America Organ Preservation Market, Revenues & Volume, By Solution, 2021 - 2031 |
6.2 North America Organ Preservation Market, Revenues & Volume, By Organ Type, 2021 - 2031 |
6.3 North America Organ Preservation Market, Revenues & Volume, By Preservation Technology, 2021 - 2031 |
7 United States Organ Preservation Market, 2021 - 2031 |
7.1 United States Organ Preservation Market, Revenues & Volume, By Solution, 2021 - 2031 |
7.2 United States Organ Preservation Market, Revenues & Volume, By Organ Type, 2021 - 2031 |
7.3 United States Organ Preservation Market, Revenues & Volume, By Preservation Technology, 2021 - 2031 |
8 Canada Organ Preservation Market, 2021 - 2031 |
8.1 Canada Organ Preservation Market, Revenues & Volume, By Solution, 2021 - 2031 |
8.2 Canada Organ Preservation Market, Revenues & Volume, By Organ Type, 2021 - 2031 |
8.3 Canada Organ Preservation Market, Revenues & Volume, By Preservation Technology, 2021 - 2031 |
9 North America Organ Preservation Market Key Performance Indicators |
10 North America Organ Preservation Market - Opportunity Assessment |
10.1 North America Organ Preservation Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Organ Preservation Market Opportunity Assessment, By Solution, 2021 & 2031F |
10.3 North America Organ Preservation Market Opportunity Assessment, By Organ Type, 2021 & 2031F |
10.4 North America Organ Preservation Market Opportunity Assessment, By Preservation Technology, 2021 & 2031F |
11 North America Organ Preservation Market - Competitive Landscape |
11.1 North America Organ Preservation Market Revenue Share, By Companies, 2024 |
11.2 North America Organ Preservation Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Company Profiles |
13 Recommendations |
14 Disclaimer |